Neuropediatrics 2014; 45(03): 169-174
DOI: 10.1055/s-0033-1364179
Original Article
Georg Thieme Verlag KG Stuttgart · New York

Hematopoietic Stem Cell Transplantation in the Leukodystrophies: A Systematic Review of the Literature

Patricia L. Musolino
1   Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts, United States
,
Troy C. Lund
2   Division of Pediatric Blood and Marrow Transplantation, University of Minnesota, Minneapolis, Minnesota, United States
,
Jessica Pan
1   Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts, United States
,
Maria L. Escolar
3   Department of Pediatrics, University of Pittsburgh, One Children's Hospital Drive, Pittsburgh, Pennsylvania, United States
,
Asif M. Paker
1   Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts, United States
,
Christine N. Duncan
4   Dana-Farber Cancer Institute, Boston Children's Hospital, Boston, Massachusetts, United States
,
Florian S. Eichler
1   Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts, United States
› Author Affiliations
Further Information

Publication History

31 August 2013

07 November 2013

Publication Date:
23 January 2014 (online)

Abstract

Objective The objective of this study is to systematically review the literature on worldwide numbers of leukodystrophy patients undergoing hematopoietic stem cell transplantation (HSCT) as well as the safety and efficacy of the procedure in this patient population.

Materials and Methods A PubMed and EMBASE search up to June 2012 was conducted with a manual search of references from relevant articles. Selected studies were evaluated using internationally accepted criteria. The effect estimates of HSCT upon survival in early-stage disease versus late-stage disease were compared.

Results One hundred and fifty-two studies qualified for inclusion and reported on a total of 689 patients. Study quality ranged from poor to good; no study was rated excellent. Small sample sizes limited most studies. Meta-analysis in a subset of larger studies indicates that transplantation in earlier stages of disease fairs better than in the late stages. Beyond survival, little longitudinal data on functional outcome is reported and neurological outcome is sparse.

Conclusion Further studies are needed to determine the neurological outcome following HSCT in the leukodystrophies. HSCT in the early stages of cerebral disease is still recommended for select leukodystrophies.

 
  • References

  • 1 Beam D, Poe MD, Provenzale JM , et al. Outcomes of unrelated umbilical cord blood transplantation for X-linked adrenoleukodystrophy. Biol Blood Marrow Transplant 2007; 13 (6) 665-674
  • 2 Baumann M, Korenke GC, Weddige-Diedrichs A , et al. Haematopoietic stem cell transplantation in 12 patients with cerebral X-linked adrenoleukodystrophy. Eur J Pediatr 2003; 162 (1) 6-14
  • 3 Escolar ML, Poe MD, Provenzale JM , et al. Transplantation of umbilical-cord blood in babies with infantile Krabbe's disease. N Engl J Med 2005; 352 (20) 2069-2081
  • 4 Miller WP, Rothman SM, Nascene D , et al. Outcomes after allogeneic hematopoietic cell transplantation for childhood cerebral adrenoleukodystrophy: the largest single-institution cohort report. Blood 2011; 118 (7) 1971-1978
  • 5 Mahmood A, Raymond GV, Dubey P, Peters C, Moser HW. Survival analysis of haematopoietic cell transplantation for childhood cerebral X-linked adrenoleukodystrophy: a comparison study. Lancet Neurol 2007; 6 (8) 687-692
  • 6 Martin PL, Carter SL, Kernan NA , et al. Results of the cord blood transplantation study (COBLT): outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with lysosomal and peroxisomal storage diseases. Biol Blood Marrow Transplant 2006; 12 (2) 184-194
  • 7 Peters C, Charnas LR, Tan Y , et al. Cerebral X-linked adrenoleukodystrophy: the international hematopoietic cell transplantation experience from 1982 to 1999. Blood 2004; 104 (3) 881-888
  • 8 Shapiro E, Krivit W, Lockman L , et al. Long-term effect of bone-marrow transplantation for childhood-onset cerebral X-linked adrenoleukodystrophy. Lancet 2000; 356 (9231) 713-718
  • 9 Siddiqi ZA, Sanders DB, Massey JM. Peripheral neuropathy in Krabbe disease: effect of hematopoietic stem cell transplantation. Neurology 2006; 67 (2) 268-272
  • 10 Melhem ER, Loes DJ, Georgiades CS, Raymond GV, Moser HW. X-linked adrenoleukodystrophy: the role of contrast-enhanced MR imaging in predicting disease progression. AJNR Am J Neuroradiol 2000; 21 (5) 839-844
  • 11 Musolino PL, Rapalino O, Caruso P, Caviness VS, Eichler FS. Hypoperfusion predicts lesion progression in cerebral X-linked adrenoleukodystrophy. Brain 2012; 135 (Pt 9) 2676-2683
  • 12 Martin HR, Poe MD, Provenzale JM, Kurtzberg J, Mendizabal A, Escolar ML. Neurodevelopmental outcomes of umbilical cord blood transplantation in metachromatic leukodystrophy. Biol Blood Marrow Transplant 2013; 19 (4) 616-624
  • 13 Escolar ML, Poe MD, Smith JK , et al. Diffusion tensor imaging detects abnormalities in the corticospinal tracts of neonates with infantile Krabbe disease. AJNR Am J Neuroradiol 2009; 30 (5) 1017-1021
  • 14 Lin M, Epport K, Azen C, Parkman R, Kohn DB, Shah AJ. Long-term neurocognitive function of pediatric patients with severe combined immune deficiency (SCID): pre- and post-hematopoietic stem cell transplant (HSCT). J Clin Immunol 2009; 29 (2) 231-237
  • 15 Shah AJ, Epport K, Azen C , et al. Progressive declines in neurocognitive function among survivors of hematopoietic stem cell transplantation for pediatric hematologic malignancies. J Pediatr Hematol Oncol 2008; 30 (6) 411-418
  • 16 Prasad VK, Kurtzberg J. Cord blood and bone marrow transplantation in inherited metabolic diseases: scientific basis, current status and future directions. Br J Haematol 2010; 148 (3) 356-372